Long COVID Patients Show Lower Levels of Brain Oxygen
THURSDAY, March 2, 2023 (HealthDay News) — People who have long COVID — lingering symptoms after a COVID-19 infection — may also have lower brain oxygen levels, cognitive problems and psychiatric troubles, such as anxiety and depression.Researchers f…
Learn MoreIs an Allergy to a COVID Vaccine Always Real? Placebo Trial Casts Doubt
THURSDAY, March 2, 2023 (HealthDay) — Allergic reactions to the Pfizer or Moderna COVID vaccines are very rare, and a new study questions whether many of those that do occur are even real.In a small new study of 16 people who said they’d experienced …
Learn MoreFDA Panel Backs Second RSV Vaccine for Older Americans
THURSDAY, March 2, 2023 (HealthDay News) — Following hours of discussion over safety concerns, a U.S. Food and Drug Administration advisory panel on Wednesday recommended approval of a second RSV vaccine, this one made by GlaxoSmithKline, for use in …
Learn MoreFDA Panel Backs Pfizer RSV Vaccine for Older Americans
WEDNESDAY, March 1, 2023 (HealthDay News) — In a tight vote, U.S. Food and Drug Administration advisers on Tuesday recommended the approval of a respiratory syncytial virus (RSV) vaccine that could be used in Americans ages 60 years and older.The vac…
Learn MoreFDA Panel Backs Pfizer’s RSV Vaccine for Older Americans
WEDNESDAY, March 1, 2023 (HealthDay News) — In a tight vote, U.S. Food and Drug Administration advisors on Tuesday recommended the approval of an RSV vaccine that could be used in Americans ages 60 and up. The vaccine, known as RENOIR, was developed …
Learn MoreBreath Analysis Shows Promise for COVID-19 Detection
TUESDAY, Feb. 28, 2023 (HealthDay News) — Breath analysis seems promising for COVID-19 detection, according to a study published online Feb. 28 in JAMA Network Open.Ruchi Sharma, Ph.D., from the University of Michigan in Ann Arbor, and colleagues exa…
Learn MorePersistent Organ Damage Common One Year After COVID-19
TUESDAY, Feb. 28, 2023 (HealthDay News) — Organ impairment persists in 59 percent of individuals one year after COVID-19, according to a study published online Feb. 14 in Journal of the Royal Society of Medicine.Andrea Dennis, Ph.D., from Perspectum …
Learn MoreLos CDC advierten de un aumento en la bacteria shigella resistente a los medicamentos
LUNES, 27 de febrero de 2023 (HealthDay News) — Las autoridades de salud pública están advirtiendo sobre un aumento en las cepas resistentes a los medicamentos de la bacteria shigella. Alrededor de un 5 por ciento de las infecciones con shigella repo…
Learn More¿COVID o gripe? La FDA aprueba la primera prueba a domicilio para ambas
LUNES, 27 de febrero de 2023 (HealthDay News) — Una nueva prueba a domicilio ayudará a las personas que sufren síntomas respiratorios superiores a saber si tienen la COVID-19 o la gripe.La Administración de Alimentos y Medicamentos (FDA) de EE. UU. a…
Learn MoreEight-Week Bedaquiline-Linezolid Noninferior for TB
TUESDAY, Feb. 28, 2023 (HealthDay News) — A strategy of eight weeks of bedaquiline-linezolid is noninferior to a standard regimen for tuberculosis, according to a study published online Feb. 20 in the New England Journal of Medicine to coincide with …
Learn More